17-73232245-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001098832.2(FAM104A):c.62C>T(p.Ser21Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000745 in 1,611,648 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001098832.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM104A | NM_001098832.2 | c.62C>T | p.Ser21Leu | missense_variant | 1/4 | ENST00000405159.8 | NP_001092302.1 | |
FAM104A | NM_032837.3 | c.62C>T | p.Ser21Leu | missense_variant | 1/3 | NP_116226.2 | ||
FAM104A | NM_001289411.1 | c.62C>T | p.Ser21Leu | missense_variant | 1/3 | NP_001276340.1 | ||
FAM104A | NM_001289410.1 | c.62C>T | p.Ser21Leu | missense_variant | 1/2 | NP_001276339.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM104A | ENST00000405159.8 | c.62C>T | p.Ser21Leu | missense_variant | 1/4 | 1 | NM_001098832.2 | ENSP00000384832 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152188Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000825 AC: 2AN: 242478Hom.: 0 AF XY: 0.0000151 AC XY: 2AN XY: 132504
GnomAD4 exome AF: 0.00000754 AC: 11AN: 1459460Hom.: 0 Cov.: 31 AF XY: 0.00000551 AC XY: 4AN XY: 725954
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152188Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2021 | The c.62C>T (p.S21L) alteration is located in exon 1 (coding exon 1) of the FAM104A gene. This alteration results from a C to T substitution at nucleotide position 62, causing the serine (S) at amino acid position 21 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at